Malignancy rates of B3-lesions in breast magnetic resonance imaging - do all lesions have to be excised?

about

Malignancy rates of B3-lesions in breast magnetic resonance imaging - do all lesions have to be excised?

Item

http://www.wikidata.org/entity/Q58755689

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Malignancy rates of B3-lesions ...... ll lesions have to be excised?

@en

Malignancy rates of B3-lesions ...... ll lesions have to be excised?

@nl

type

Item

label

Malignancy rates of B3-lesions ...... ll lesions have to be excised?

@en

Malignancy rates of B3-lesions ...... ll lesions have to be excised?

@nl

prefLabel

Malignancy rates of B3-lesions ...... ll lesions have to be excised?

@en

Malignancy rates of B3-lesions ...... ll lesions have to be excised?

@nl

P1476

Malignancy rates of B3-lesions ...... ll lesions have to be excised?

@en

P2093

A Staebler

http://www.w3.org/2001/XMLSchema#string

H Preibsch

http://www.w3.org/2001/XMLSchema#string

K C Siegmann-Luz

http://www.w3.org/2001/XMLSchema#string

L K Wanner

http://www.w3.org/2001/XMLSchema#string

M Hahn

http://www.w3.org/2001/XMLSchema#string

P2860

First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)

Surgical outcomes of borderline breast lesions detected by needle biopsy in a breast screening program

Nonmalignant lesions in breast core needle biopsies: to excise or not to excise?

Lesions with unclear malignant potential (B3) after minimally invasive breast biopsy: evaluation of vacuum biopsies performed in Switzerland and recommended further management.

European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document.

Update on percutaneous needle biopsy of nonmalignant breast lesions.

Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012.

High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: can underestimation be predicted?

Management of breast lesions detectable only on MRI.

Underestimation Rate at MR Imaging-guided Vacuum-assisted Breast Biopsy: A Multi-Institutional Retrospective Study of 1509 Breast Biopsies.

P2888

s12880-018-0271-7

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12880-018-0271-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106906165

http://www.w3.org/2001/XMLSchema#string

P698

30200900

http://www.w3.org/2001/XMLSchema#string

P932

6131767

http://www.w3.org/2001/XMLSchema#string